{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:36:01Z","timestamp":1776458161252,"version":"3.51.2"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI036214"],"award-info":[{"award-number":["P30AI036214"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA023356"],"award-info":[{"award-number":["T32DA023356"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R03DA57142"],"award-info":[{"award-number":["R03DA57142"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA043412"],"award-info":[{"award-number":["K01DA043412"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HIV self-testing (HIVST) could increase HIV testing access among people who inject drugs (PWID), and secondary distribution (i.e., peer-delivery) of HIVST kits in PWID social networks could further expand coverage. We assessed willingness to use and distribute\u00a0HIVST\u00a0kits among PWID in the San Diego\u2013Tijuana border region.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From 2020 to 2021, HIV-negative PWID in San Diego, USA, and Tijuana, Mexico, completed surveys and provided data on individual (<jats:italic>N<\/jats:italic>\u2009=\u2009539) and social network (<jats:italic>N<\/jats:italic>\u2009=\u2009366) characteristics. We used modified Poisson regression to examine the effects of individual and social network characteristics on willingness to use and distribute\u00a0HIVST\u00a0kits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Most participants were willing to use\u00a0(81%) and distribute (81%) HIVST\u00a0kits. At the individual level, prior HIV testing was positively associated with willingness to use (adjusted prevalence ratio [aPR]\u2009=\u20091.24, 95% confidence interval [CI] 1.10\u20131.40) and distribute (aPR\u2009=\u20091.27, 95% CI 1.12\u20131.43) HIVST\u00a0kits, while perceiving oneself to be at higher HIV risk than others was negatively associated with willingness to use HIVST kits (aPR\u2009=\u20090.83, 95% CI 0.74\u20130.93). At the network level, willingness to distribute\u00a0HIVST\u00a0kits was positively associated with network size (aPR\u2009=\u20091.04 per member, 95% CI 1.01\u20131.08) and greater proportions of one\u2019s network encouraging them to use drugs (aPR\u2009=\u20091.29, 95% CI 1.16\u20131.44) and having a history of homelessness (aPR\u2009=\u20091.51, 95% CI 1.31\u20131.74) or detention\/arrest (aPR\u2009=\u20091.57, 95% CI 1.36\u20131.82), and negatively associated with a greater proportion of one\u2019s network including \u201cvery close\u201d persons (aPR\u2009=\u20090.80, 95% CI 0.69\u20130.94).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found high potential for HIVST kits\u00a0and their secondary distribution to increase HIV testing among PWID who face the greatest barriers to facility-based testing.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-023-00922-7","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T21:13:48Z","timestamp":1704316428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego\u2013Tijuana border region"],"prefix":"10.1186","volume":"21","author":[{"given":"Heather A.","family":"Pines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Eger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britt","family":"Skaathun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos F.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Harvey-Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudelia","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffanie A.","family":"Strathdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela R.","family":"Bazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"922_CR1","unstructured":"UNAIDS. UNAIDS Data. 2021. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC3032_AIDS_Data_book_2021_En.pdf. Accessed August 25, 2022."},{"key":"922_CR2","unstructured":"United Nations Office on Drugs and Crime. Systematic Literature Review on HIV and Stimulant Drug Use \u2013\u00a0ATS and HIV Risk and Transmission. Vol Part 2\/52017."},{"issue":"34","key":"922_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","volume":"68","author":"RM Gladden","year":"2019","unstructured":"Gladden RM, O\u2019Donnell J, Mattson CL, Seth P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine - 25 States, July-December 2017 to January-June 2018. MMWR Morb Mortal Wkly Rep. 2019;68(34):737\u201344.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"922_CR4","unstructured":"Volkow N. Rising stimulant deaths show that we face more than just an opioid crisis. Nora\u2019s Blog: National Institute on Drug Abuse (NIDA); 2020."},{"issue":"12","key":"922_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/apc.2018.0126","volume":"32","author":"AR Bazzi","year":"2018","unstructured":"Bazzi AR, Biancarelli DL, Childs E, et al. Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care STDS. 2018;32(12):529\u201337.","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"922_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/infdis\/jiaa017","volume":"222","author":"L Bull-Otterson","year":"2020","unstructured":"Bull-Otterson L, Huang YA, Zhu W, King H, Edlin BR, Hoover KW. Human immunodeficiency virus and hepatitis C virus infection testing among commercially insured persons who inject drugs, United States, 2010\u20132017. J Infect Dis. 2020;222(6):940\u20137.","journal-title":"J Infect Dis"},{"issue":"11","key":"922_CR7","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s11606-022-07436-1","volume":"37","author":"J Alves","year":"2022","unstructured":"Alves J, Stewart J, Ruiz-Mercado G, Taylor JL. When perfect is the enemy of tested: a call to scale rapid HIV testing for people who inject drugs. J Gen Intern Med. 2022;37(11):2851\u20132582.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"922_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.24875\/AIDSRev.21000007","volume":"24","author":"SO Gbadamosi","year":"2022","unstructured":"Gbadamosi SO, Trepka MJ, Dawit R, Jebai R, Sheehan DM. A systematic review and meta-analysis to estimate the time from HIV infection to diagnosis for people with HIV. AIDS Rev. 2022;24(1):32\u201340.","journal-title":"AIDS Rev"},{"key":"922_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108280","volume":"124","author":"JL Taylor","year":"2021","unstructured":"Taylor JL, Ruiz-Mercado G, Sperring H, Bazzi AR. A collision of crises: addressing an HIV outbreak among people who inject drugs in the midst of COVID-19. J Subst Abuse Treat. 2021;124: 108280.","journal-title":"J Subst Abuse Treat"},{"key":"922_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100159","author":"E Moitra","year":"2022","unstructured":"Moitra E, Tao J, Olsen J, et al. Impact of the COVID-19 pandemic on HIV testing rates across four geographically diverse urban centres in the United States: An observational study. The LANCET Regional Health\u2013Americas. 2022. https:\/\/doi.org\/10.1016\/j.lana.2021.100159.","journal-title":"The LANCET Regional Health\u2013Americas"},{"key":"922_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.socscimed.2015.02.018","volume":"130","author":"SE Burke","year":"2015","unstructured":"Burke SE, Calabrese SK, Dovidio JF, et al. A tale of two cities: stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-J\u00e4rve, Estonia. Soc Sci Med. 2015;130:154\u201361.","journal-title":"Soc Sci Med"},{"issue":"1","key":"922_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10461-015-1100-4","volume":"20","author":"SK Calabrese","year":"2016","unstructured":"Calabrese SK, Burke SE, Dovidio JF, et al. Internalized HIV and drug stigmas: interacting forces threatening health status and health service utilization among people with HIV who inject drugs in St. Petersburg, Russia. AIDS Behav. 2016;20(1):85\u201397.","journal-title":"AIDS Behav"},{"key":"922_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"922_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11606-020-06201-6","volume":"36","author":"D Motavalli","year":"2021","unstructured":"Motavalli D, Taylor JL, Childs E, et al. Health is on the back burner: multilevel barriers and facilitators to primary care among people who inject drugs. J Gen Intern Med. 2021;36(1):129\u201337.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"922_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/10550887.2020.1771235","volume":"38","author":"A Bayani","year":"2020","unstructured":"Bayani A, Ghiasvand H, Rezaei O, et al. Factors associated with HIV testing among people who inject drugs: a meta-analysis. J Addict Dis. 2020;38(3):361\u201374.","journal-title":"J Addict Dis"},{"issue":"14","key":"922_CR16","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1097\/QAD.0000000000002673","volume":"34","author":"SA Strathdee","year":"2020","unstructured":"Strathdee SA, Kuo I, El-Bassel N, Hodder S, Smith LR, Springer SA. Preventing HIV outbreaks among people who inject drugs in the United States: plus \u00e7a change, plus \u00e7a m\u00eame chose. AIDS. 2020;34(14):1997\u20132005.","journal-title":"AIDS"},{"issue":"9","key":"922_CR17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844\u20135.","journal-title":"JAMA"},{"issue":"11","key":"922_CR18","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s10461-015-1097-8","volume":"19","author":"C Figueroa","year":"2015","unstructured":"Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav. 2015;19(11):1949\u201365.","journal-title":"AIDS Behav"},{"issue":"Suppl 4","key":"922_CR19","doi-asserted-by":"publisher","first-page":"S391","DOI":"10.1007\/s10461-014-0832-x","volume":"18","author":"C Johnson","year":"2014","unstructured":"Johnson C, Baggaley R, Forsythe S, et al. Realizing the potential for HIV self-testing. AIDS Behav. 2014;18(Suppl 4):S391-395.","journal-title":"AIDS Behav"},{"issue":"6","key":"922_CR20","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S2352-3018(18)30044-4","volume":"5","author":"C Figueroa","year":"2018","unstructured":"Figueroa C, Johnson C, Ford N, et al. Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis. Lancet HIV. 2018;5(6):e277\u201390.","journal-title":"Lancet HIV"},{"issue":"4","key":"922_CR21","doi-asserted-by":"publisher","first-page":"e1018","DOI":"10.1093\/cid\/ciab029","volume":"73","author":"I Eshun-Wilson","year":"2021","unstructured":"Eshun-Wilson I, Jamil MS, Witzel TC, et al. A systematic review and network meta-analyses to assess the effectiveness of human immunodeficiency virus (HIV) self-testing distribution strategies. Clin Infect Dis. 2021;73(4):e1018\u201328.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"922_CR22","doi-asserted-by":"publisher","first-page":"21594","DOI":"10.7448\/IAS.20.1.21594","volume":"20","author":"CC Johnson","year":"2017","unstructured":"Johnson CC, Kennedy C, Fonner V, et al. Examining the effects of HIV self-testing compared to standard HIV testing services: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21594.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"922_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12916-020-01835-z","volume":"18","author":"TC Witzel","year":"2020","unstructured":"Witzel TC, Eshun-Wilson I, Jamil MS, et al. Comparing the effects of HIV self-testing to standard HIV testing for key populations: a systematic review and meta-analysis. BMC Med. 2020;18(1):381.","journal-title":"BMC Med"},{"issue":"7","key":"922_CR24","doi-asserted-by":"publisher","first-page":"e977","DOI":"10.1016\/S2214-109X(21)00175-3","volume":"9","author":"AT Choko","year":"2021","unstructured":"Choko AT, Fielding K, Johnson CC, et al. Partner-delivered HIV self-test kits with and without financial incentives in antenatal care and index patients with HIV in Malawi: a three-arm, cluster-randomised controlled trial. Lancet Glob Health. 2021;9(7):e977\u201388.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"922_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/QAI.0000000000001838","volume":"79","author":"A Gichangi","year":"2018","unstructured":"Gichangi A, Wambua J, Mutwiwa S, et al. Impact of HIV self-test distribution to male partners of ANC clients: results of a randomized controlled trial in Kenya. J Acquir Immune Defic Syndr. 2018;79(4):467\u201373.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"922_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002166","volume":"13","author":"SH Masters","year":"2016","unstructured":"Masters SH, Agot K, Obonyo B, Napierala Mavedzenge S, Maman S, Thirumurthy H. Promoting partner testing and couples testing through secondary distribution of HIV self-tests: a randomized clinical trial. PLoS Med. 2016;13(11): e1002166.","journal-title":"PLoS Med"},{"issue":"Suppl 2","key":"922_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25515","volume":"23","author":"S Napierala","year":"2020","unstructured":"Napierala S, Bair EF, Marcus N, et al. Male partner testing and sexual behaviour following provision of multiple HIV self-tests to Kenyan women at higher risk of HIV infection in a cluster randomized trial. J Int AIDS Soc. 2020;23(Suppl 2): 025515.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"922_CR28","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1016\/S2352-3018(21)00248-4","volume":"8","author":"H Thirumurthy","year":"2021","unstructured":"Thirumurthy H, Bair EF, Ochwal P, et al. The effect of providing women sustained access to HIV self-tests on male partner testing, couples testing, and HIV incidence in Kenya: a cluster-randomised trial. Lancet HIV. 2021;8(12):e736\u201346.","journal-title":"Lancet HIV"},{"issue":"1","key":"922_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/QAI.0000000000001726","volume":"79","author":"MA Lightfoot","year":"2018","unstructured":"Lightfoot MA, Campbell CK, Moss N, et al. Using a social network strategy to distribute HIV self-test kits to African American and Latino MSM. J Acquir Immune Defic Syndr. 2018;79(1):38\u201345.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"922_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10461-020-03034-6","volume":"25","author":"AM Ballard","year":"2021","unstructured":"Ballard AM, Haard\u00f6erfer R, Prood N, Mbagwu C, Cooper HLF, Young AM. Willingness to participate in At-home HIV testing among young adults who use opioids in rural Appalachia. AIDS Behav. 2021;25(3):699\u2013708.","journal-title":"AIDS Behav"},{"key":"922_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103613","volume":"103","author":"NC Peiper","year":"2022","unstructured":"Peiper NC, Shamblen S, Gilbertson A, et al. Acceptability of a HIV self-testing program among people who use illicit drugs. Int J Drug Policy. 2022;103: 103613.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"922_CR32","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/S2352-3018(16)30040-6","volume":"3","author":"RE Booth","year":"2016","unstructured":"Booth RE, Davis JM, Dvoryak S, et al. HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial. Lancet HIV. 2016;3(10):e482-489.","journal-title":"Lancet HIV"},{"issue":"4","key":"922_CR33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.socscimed.2008.11.019","volume":"68","author":"CA Latkin","year":"2009","unstructured":"Latkin CA, Donnell D, Metzger D, et al. The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med. 2009;68(4):740\u20138.","journal-title":"Soc Sci Med"},{"issue":"4","key":"922_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1037\/0278-6133.22.4.332","volume":"22","author":"CA Latkin","year":"2003","unstructured":"Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332\u20139.","journal-title":"Health Psychol"},{"issue":"2","key":"922_CR35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1360-0443.2010.03146.x","volume":"106","author":"KE Tobin","year":"2011","unstructured":"Tobin KE, Kuramoto SJ, Davey-Rothwell MA, Latkin CA. The STEP into action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction. 2011;106(2):366\u201375.","journal-title":"Addiction"},{"issue":"4","key":"922_CR36","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10461-016-1413-y","volume":"21","author":"D Ghosh","year":"2017","unstructured":"Ghosh D, Krishnan A, Gibson B, Brown SE, Latkin CA, Altice FL. Social network strategies to address HIV prevention and treatment continuum of care among at-risk and HIV-infected substance users: a systematic scoping review. AIDS Behav. 2017;21(4):1183\u2013207.","journal-title":"AIDS Behav"},{"key":"922_CR37","doi-asserted-by":"publisher","first-page":"38100","DOI":"10.1038\/srep38100","volume":"6","author":"GK Nikolopoulos","year":"2016","unstructured":"Nikolopoulos GK, Pavlitina E, Muth SQ, et al. A network intervention that locates and intervenes with recently HIV-infected persons: the transmission reduction intervention project (TRIP). Sci Rep. 2016;6:38100.","journal-title":"Sci Rep"},{"issue":"2","key":"922_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1521\/aeap.17.3.170.62900","volume":"17","author":"D Huo","year":"2005","unstructured":"Huo D, Bailey SL, Hershow RC, Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Educ Prev. 2005;17(2):170\u201384.","journal-title":"AIDS Educ Prev"},{"issue":"9","key":"922_CR39","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1080\/10826084.2017.1299182","volume":"52","author":"CN Behrends","year":"2017","unstructured":"Behrends CN, Li CS, Gibson DR. Decreased odds of injection risk behavior associated with direct versus indirect use of syringe exchange: evidence from two California Cities. Subst Use Misuse. 2017;52(9):1151\u20139.","journal-title":"Subst Use Misuse"},{"key":"922_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugpo.2018.02.008","volume":"55","author":"C Keane","year":"2018","unstructured":"Keane C, Egan JE, Hawk M. Effects of naloxone distribution to likely bystanders: results of an agent-based model. Int J Drug Policy. 2018;55:61\u20139.","journal-title":"Int J Drug Policy"},{"issue":"22","key":"922_CR41","doi-asserted-by":"publisher","first-page":"12073","DOI":"10.3390\/ijerph182212073","volume":"18","author":"F Mercer","year":"2021","unstructured":"Mercer F, Miler JA, Pauly B, et al. Peer support and overdose prevention responses: a systematic \u201cstate-of-the-art\u201d review. Int J Environ Res Public Health. 2021;18(22):12073.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"922_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.annepidem.2012.04.002","volume":"22","author":"SA Strathdee","year":"2012","unstructured":"Strathdee SA, Magis-Rodriguez C, Mays VM, Jimenez R, Patterson TL. The emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response. Ann Epidemiol. 2012;22(6):426\u201338.","journal-title":"Ann Epidemiol."},{"issue":"5","key":"922_CR43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s10461-015-1186-8","volume":"20","author":"LR Smith","year":"2016","unstructured":"Smith LR, Patterson TL, Magis-Rodriguez C, et al. Engagement in the HIV care continuum among key populations in Tijuana. Mexico AIDS Behav. 2016;20(5):1017\u201325.","journal-title":"Mexico AIDS Behav"},{"issue":"11","key":"922_CR44","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1007\/s10461-021-03361-2","volume":"25","author":"H Fraser","year":"2021","unstructured":"Fraser H, Borquez A, Stone J, et al. Overlapping key populations and HIV transmission in Tijuana, Mexico: a modelling analysis of epidemic drivers. AIDS Behav. 2021;25(11):3814\u201327.","journal-title":"AIDS Behav"},{"issue":"10","key":"922_CR45","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3109\/10826084.2015.1013132","volume":"50","author":"MC Meacham","year":"2015","unstructured":"Meacham MC, Rudolph AE, Strathdee SA, et al. Polydrug use and HIV risk among people who inject heroin in Tijuana, Mexico: a latent class analysis. Subst Use Misuse. 2015;50(10):1351\u20139.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"922_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/dar.12524","volume":"37","author":"MC Meacham","year":"2018","unstructured":"Meacham MC, Roesch SC, Strathdee SA, Lindsay S, Gonzalez-Zuniga P, Gaines TL. Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California. Mexico Drug Alcohol Rev. 2018;37(1):128\u201336.","journal-title":"Mexico Drug Alcohol Rev"},{"issue":"8","key":"922_CR47","volume":"13","author":"J Pergolizzi","year":"2021","unstructured":"Pergolizzi J, Magnusson P, LeQuang JAK, Breve F. Illicitly manufactured fentanyl entering the United States. Cureus. 2021;13(8): e17496.","journal-title":"Cureus"},{"key":"922_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","volume":"74","author":"BH Lambdin","year":"2019","unstructured":"Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy. 2019;74:299\u2013304.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"922_CR49","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/08897077.2019.1675118","volume":"40","author":"JL Taylor","year":"2019","unstructured":"Taylor JL, Walley AY, Bazzi AR. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs. Subst Abus. 2019;40(4):441\u20133.","journal-title":"Subst Abus"},{"issue":"14","key":"922_CR50","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1056\/NEJMc1510396","volume":"373","author":"J Adams","year":"2015","unstructured":"Adams J. HIV outbreak in Indiana. N Engl J Med. 2015;373(14):1379\u201380.","journal-title":"N Engl J Med"},{"issue":"10","key":"922_CR51","doi-asserted-by":"publisher","first-page":"e569","DOI":"10.1016\/S2352-3018(18)30176-0","volume":"5","author":"GS Gonsalves","year":"2018","unstructured":"Gonsalves GS, Crawford FW. Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011\u201315: a modelling study. Lancet HIV. 2018;5(10):e569\u201377.","journal-title":"Lancet HIV"},{"key":"922_CR52","unstructured":"MDPH Clinical Advisory: Statewide Outbreak of HIV Infection in Persons who Inject Drugs. In: Department of Public Health, ed: Massachusetts Executive Office of Health and Human Services; 2019."},{"issue":"10","key":"922_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15585\/mmwr.mm6810a6","volume":"68","author":"K Cranston","year":"2019","unstructured":"Cranston K, Alpren C, John B, et al. Notes from the Field: HIV diagnoses among persons who inject drugs - Northeastern Massachusetts, 2015\u20132018. MMWR Morb Mortal Wkly Rep. 2019;68(10):253\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"922_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","volume":"110","author":"C Alpren","year":"2020","unstructured":"Alpren C, Dawson EL, John B, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs-Massachusetts, 2015\u20132018. Am J Public Health. 2020;110(1):37\u201344.","journal-title":"Am J Public Health"},{"issue":"15","key":"922_CR55","doi-asserted-by":"publisher","first-page":"344","DOI":"10.15585\/mmwr.mm6815a2","volume":"68","author":"MR Golden","year":"2019","unstructured":"Golden MR, Lechtenberg R, Glick SN, et al. Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(15):344\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"922_CR56","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/15332640.2012.735182","volume":"11","author":"KD Wagner","year":"2012","unstructured":"Wagner KD, Moynihan MJ, Strathdee SA, et al. The social and environmental context of cross-border drug use in Mexico: findings from a mixed methods study of young injection drug users living in San Diego, CA. J Ethn Subst Abuse. 2012;11(4):362\u201378.","journal-title":"J Ethn Subst Abuse"},{"key":"922_CR57","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drugpo.2016.12.010","volume":"41","author":"EF Wood","year":"2017","unstructured":"Wood EF, Werb D, Beletsky L, et al. Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego. Int J Drug Policy. 2017;41:132\u20139.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"922_CR58","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.ebiom.2015.07.024","volume":"2","author":"SR Mehta","year":"2015","unstructured":"Mehta SR, Wertheim JO, Brouwer KC, et al. HIV transmission networks in the San Diego\u2013Tijuana Border region. EBioMedicine. 2015;2(10):1456\u201363.","journal-title":"EBioMedicine"},{"issue":"7","key":"922_CR59","doi-asserted-by":"publisher","first-page":"e2018","DOI":"10.1093\/cid\/ciaa1588","volume":"73","author":"B Vrancken","year":"2021","unstructured":"Vrancken B, Mehta SR, \u00c1vila-R\u00edos S, et al. Dynamics and dispersal of local human immunodeficiency virus epidemics within San Diego and across the San Diego\u2013Tijuana Border. Clin Infect Dis. 2021;73(7):e2018\u201325.","journal-title":"Clin Infect Dis"},{"key":"922_CR60","unstructured":"Pines HA, Mehta SR, Abramovitz D, et al. Dynamics of HIV transmission between high-risk populations in Tijuana. Conference on Retroviruses and Opportunistic Infections (CROI); March 2021; Virtual."},{"issue":"11","key":"922_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260286","volume":"16","author":"SA Strathdee","year":"2021","unstructured":"Strathdee SA, Abramovitz D, Harvey-Vera A, et al. Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego\u2013Tijuana border region. PLoS ONE. 2021;16(11): e0260286.","journal-title":"PLoS ONE"},{"issue":"16","key":"922_CR62","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP) Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789\u201395.","journal-title":"Arch Intern Med."},{"issue":"10","key":"922_CR63","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/aje\/kwg074","volume":"157","author":"LA McNutt","year":"2003","unstructured":"McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940\u20133.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"922_CR64","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"922_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10(1):37\u201348.","journal-title":"Epidemiology"},{"issue":"2","key":"922_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00126334-200106010-00015","volume":"27","author":"C Sears","year":"2001","unstructured":"Sears C, Guydish JR, Weltzien EK, Lum PJ. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, USA. J Acquir Immune Defic Syndr. 2001;27(2):193\u2013201.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"922_CR67","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drugalcdep.2018.11.021","volume":"195","author":"R Glass","year":"2019","unstructured":"Glass R, Hope VD, Njoroge J, et al. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012\u201315. Drug Alcohol Depend. 2019;195:40\u20134.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"922_CR68","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12879-022-07484-2","volume":"22","author":"E Fajardo","year":"2022","unstructured":"Fajardo E, Watson V, Kumwenda M, et al. Usability and acceptability of oral-based HCV self-testing among key populations: a mixed-methods evaluation in Tbilisi, Georgia. BMC Infect Dis. 2022;22(1):510.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"922_CR69","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12879-022-07712-9","volume":"22","author":"E Ivanova Reipold","year":"2022","unstructured":"Ivanova Reipold E, Fajardo E, Juma E, et al. Usability and acceptability of oral fluid hepatitis C self-testing among people who inject drugs in Coastal Kenya: a cross-sectional pilot study. BMC Infect Dis. 2022;22(1):738.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"922_CR70","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/diagnostics11020377","volume":"11","author":"LT Nguyen","year":"2021","unstructured":"Nguyen LT, Nguyen VTT, Le Ai KA, et al. Acceptability and usability of HCV self-testing in high risk populations in Vietnam. Diagnostics (Basel). 2021;11(2):377.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"922_CR71","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12889-023-15429-w","volume":"23","author":"AR Bazzi","year":"2023","unstructured":"Bazzi AR, Bordeu M, Baumgartner K, et al. Study protocol for an efficacy trial of the \u201cPrEP for Health\u201d intervention to increase HIV PrEP use among people who inject drugs. BMC Public Health. 2023;23(1):513.","journal-title":"BMC Public Health"},{"issue":"1","key":"922_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12954-018-0263-5","volume":"15","author":"KB Biello","year":"2018","unstructured":"Biello KB, Bazzi AR, Mimiaga MJ, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15(1):55.","journal-title":"Harm Reduct J"},{"key":"922_CR73","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/002204260403400201","volume":"34","author":"S Murphy","year":"2004","unstructured":"Murphy S, Kelley MS, Lune H. The health benefits of secondary syringe exchange. J Drug Issues. 2004;34:245\u201368.","journal-title":"J Drug Issues"},{"issue":"1","key":"922_CR74","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13722-022-00358-7","volume":"18","author":"E Romo","year":"2023","unstructured":"Romo E, Rudolph AE, Stopka TJ, Wang B, Jesdale BM, Friedmann PD. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England. Addict Sci Clin Pract. 2023;18(1):2.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"922_CR75","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12889-023-15153-5","volume":"23","author":"LC Shaw","year":"2023","unstructured":"Shaw LC, Biello KB, Vahey S, Brody JK, Bazzi AR. PrEP disclosure and discussions within social networks of people who inject drugs experiencing homelessness: a brief report. BMC Public Health. 2023;23(1):263.","journal-title":"BMC Public Health"},{"key":"922_CR76","doi-asserted-by":"publisher","first-page":"1121478","DOI":"10.3389\/frph.2023.1121478","volume":"5","author":"AE Fischer","year":"2023","unstructured":"Fischer AE, Abrahams M, Shankland L, Lalla-Edward ST, Edward VA, De Wit J. The evolution of HIV self-testing and the introduction of digital interventions to improve HIV self-testing. Front Reprod Health. 2023;5:1121478.","journal-title":"Front Reprod Health"},{"issue":"4","key":"922_CR77","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/08897077.2016.1176980","volume":"37","author":"KM Collins","year":"2016","unstructured":"Collins KM, Armenta RF, Cuevas-Mota J, Liu L, Strathdee SA, Garfein RS. Factors associated with patterns of mobile technology use among persons who inject drugs. Subst Abus. 2016;37(4):606\u201312.","journal-title":"Subst Abus"},{"issue":"2","key":"922_CR78","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.3437","volume":"3","author":"A Genz","year":"2015","unstructured":"Genz A, Kirk G, Piggott D, Mehta SH, Linas BS, Westergaard RP. Uptake and acceptability of information and communication technology in a community-based cohort of people who inject drugs: implications for mobile health interventions. JMIR Mhealth Uhealth. 2015;3(2): e70.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"922_CR79","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/08897077.2021.1975871","volume":"43","author":"JE Ozga","year":"2022","unstructured":"Ozga JE, Paquette C, Syvertsen JL, Pollini RA. Mobile phone and internet use among people who inject drugs: implications for mobile health interventions. Subst Abus. 2022;43(1):592\u20137.","journal-title":"Subst Abus"},{"issue":"11","key":"922_CR80","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/OLQ.0000000000000516","volume":"43","author":"AM Roth","year":"2016","unstructured":"Roth AM, Goldshear JL, Martinez-Donate AP, Welles S, Chavis M, Van Der Pol B. Reducing missed opportunities: pairing sexually transmitted infection screening with syringe exchange services. Sex Transm Dis. 2016;43(11):706\u20138.","journal-title":"Sex Transm Dis"},{"issue":"3","key":"922_CR81","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","volume":"86","author":"AM Roth","year":"2021","unstructured":"Roth AM, Tran NK, Felsher M, et al. Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the project SHE demonstration study. J Acquir Immune Defic Syndr. 2021;86(3):e61\u201370.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00922-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00922-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00922-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T21:19:43Z","timestamp":1704316783000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00922-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00922-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"17 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committees at the University of California, San Diego and Xochicalco University approved all study procedures. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}